Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma
Angelica Benavides-Serrato(VA Greater Los Angeles Healthcare System), Joseph Gera(University of California, Los Angeles)
Cited by 33
Related Papers
AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc Expression
|Journal of Biological Chemistry|2004|329
Heterogeneous Nuclear Ribonucleoprotein A1 Regulates Cyclin D1 and c-myc Internal Ribosome Entry Site Function through Akt Signaling
|Journal of Biological Chemistry|2008|125